An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects
Status:
Completed
Trial end date:
2018-09-04
Target enrollment:
Participant gender:
Summary
This is a study to investigate the experimental medication BMS-986165 in healthy participants
in order to study the effects it has on electrocardiogram results.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
BMS-986165 Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination